218 related articles for article (PubMed ID: 26530282)
41. In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model.
Oh EJ; Lee HW; Kalimuthu S; Kim TJ; Kim HM; Baek SH; Zhu L; Oh JM; Son SH; Chung HY; Ahn BC
J Control Release; 2018 Jun; 279():79-88. PubMed ID: 29655989
[TBL] [Abstract][Full Text] [Related]
42. Exosome-educated macrophages and exosomes differentially improve ligament healing.
Chamberlain CS; Kink JA; Wildenauer LA; McCaughey M; Henry K; Spiker AM; Halanski MA; Hematti P; Vanderby R
Stem Cells; 2021 Jan; 39(1):55-61. PubMed ID: 33141458
[TBL] [Abstract][Full Text] [Related]
43. Enhanced differentiation of mesenchymal stem cells co-cultured with ligament fibroblasts on gelatin/silk fibroin hybrid scaffold.
Fan H; Liu H; Toh SL; Goh JC
Biomaterials; 2008 Mar; 29(8):1017-27. PubMed ID: 18023476
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.
Redondo-Castro E; Cunningham C; Miller J; Martuscelli L; Aoulad-Ali S; Rothwell NJ; Kielty CM; Allan SM; Pinteaux E
Stem Cell Res Ther; 2017 Apr; 8(1):79. PubMed ID: 28412968
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal Stem Cells Modified with Heme Oxygenase-1 Have Enhanced Paracrine Function and Attenuate Lipopolysaccharide-Induced Inflammatory and Oxidative Damage in Pulmonary Microvascular Endothelial Cells.
Chen X; Zhang Y; Wang W; Liu Z; Meng J; Han Z
Cell Physiol Biochem; 2018; 49(1):101-122. PubMed ID: 30153667
[TBL] [Abstract][Full Text] [Related]
46. Substance P enhances the therapeutic effect of MSCs by modulating their angiogenic potential.
Hong HS; Kim S; Jin Y; Son Y
J Cell Mol Med; 2020 Nov; 24(21):12560-12571. PubMed ID: 32985796
[TBL] [Abstract][Full Text] [Related]
47. A review on different methods to increase the efficiency of mesenchymal stem cell-based wound therapy.
Shojaei F; Rahmati S; Banitalebi Dehkordi M
Wound Repair Regen; 2019 Nov; 27(6):661-671. PubMed ID: 31298446
[TBL] [Abstract][Full Text] [Related]
48. Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats.
Seebach C; Henrich D; Kähling C; Wilhelm K; Tami AE; Alini M; Marzi I
Tissue Eng Part A; 2010 Jun; 16(6):1961-70. PubMed ID: 20088701
[TBL] [Abstract][Full Text] [Related]
49. Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure.
Zheng YB; Zhang XH; Huang ZL; Lin CS; Lai J; Gu YR; Lin BL; Xie DY; Xie SB; Peng L; Gao ZL
PLoS One; 2012; 7(7):e41392. PubMed ID: 22844472
[TBL] [Abstract][Full Text] [Related]
50. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
51. The influence of interleukin-4 on ligament healing.
Chamberlain CS; Leiferman EM; Frisch KE; Wang S; Yang X; Brickson SL; Vanderby R
Wound Repair Regen; 2011; 19(3):426-35. PubMed ID: 21518087
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal stem cells improve wound healing in vivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor.
Kim CH; Lee JH; Won JH; Cho MK
J Korean Med Sci; 2011 Jun; 26(6):726-33. PubMed ID: 21655056
[TBL] [Abstract][Full Text] [Related]
53. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
54. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
[TBL] [Abstract][Full Text] [Related]
55. Microparticles Locally Deliver Active Interleukin-1 Receptor Antagonist In Vivo.
Clements AEB; Groves ER; Chamberlain CS; Vanderby R; Murphy WL
Adv Healthc Mater; 2018 Aug; 7(16):e1800263. PubMed ID: 29974661
[TBL] [Abstract][Full Text] [Related]
56. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease.
Lee KC; Lin HC; Huang YH; Hung SC
J Hepatol; 2015 Dec; 63(6):1405-12. PubMed ID: 26276675
[TBL] [Abstract][Full Text] [Related]
57. Mesenchymal stem cells from a hypoxic culture improve and engraft Achilles tendon repair.
Huang TF; Yew TL; Chiang ER; Ma HL; Hsu CY; Hsu SH; Hsu YT; Hung SC
Am J Sports Med; 2013 May; 41(5):1117-25. PubMed ID: 23539044
[TBL] [Abstract][Full Text] [Related]
58. The Importance of Pericytes in Healing: Wounds and other Pathologies.
Thomas H; Cowin AJ; Mills SJ
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538706
[TBL] [Abstract][Full Text] [Related]
59. Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly-mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair.
Kaushik K; Das A
Cytotherapy; 2019 Feb; 21(2):260-273. PubMed ID: 30738643
[TBL] [Abstract][Full Text] [Related]
60. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
